On the Record · LivaNova
LivaNova competitors, on the record
The companies LivaNova names as competitors in its annual reports, 2023 to 2025, and the companies that name LivaNova, each with the sentence and the filing.
Who LivaNova names
| Company | Named in |
|---|---|
| Haemonetics Corporation | 2025 |
| Maquet Medical Systems | 2025 |
| Medtronic plc | 2025 |
| NeuroPace, Inc. | 2025 |
| Spectrum Medical Limited | 2025 |
| Terumo Medical Corporation | 2025 |
In its own words
Haemonetics Corporation, Maquet Medical Systems, Medtronic plc, NeuroPace, Inc., Spectrum Medical Limited, Terumo Medical Corporation
Word for word“LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation, Spectrum Medical Limited, and NeuroPace, Inc., although not all competitors are present in all product lines.” 10-K for 2025
Who names LivaNova
Companies whose own annual reports name LivaNova as a competitor.
Word for word“In addition, there are a number of companies, including Cardiovascular Systems Inc., Abbott Laboratories, Medtronic, Edwards Lifesciences, Boston Scientific, LivaNova, Terumo Heart, Teleflex, Getinge (Maquet Cardiovascular) and several early-stage companies, that are developing medical devices that provide circulatory support and oxygenation, including implantable left ventricular assist devices, miniaturized rotary ventricular assist devices and cardiopulmonary bypass devices that directly and indirectly compete with our products.” 10-K for 2022
Read from LivaNova’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.